Evidence map›Paper›PMID 18287524›Full record

ArticleMolecular biology of the cell2008

p204 protein overcomes the inhibition of core binding factor alpha-1-mediated osteogenic differentiation by Id helix-loop-helix proteins.

Yi Luan, Xiu-Ping Yu, Ning Yang, Sally Frenkel, Lin Chen, Chuan-Ju Liu

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Non-coding RNAs in ossification of spinal ligament.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Transcription factor Zeb2 regulates commitment to plasmacytoid dendritic cell and monocyte fate.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Effect of Id1 knockdown on formation of osteolytic bone lesions by prostate cancer PC3 cells in vivo.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2012
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Yi LuanDepartment of Orthopaedic Surgery, New York University School of Medicine, New York, NY 10003, USA.
Xiu-Ping Yu
Ning Yang
Sally Frenkel
Lin Chen
Chuan-Ju Liu
Shandong University · CNNew York University · USArmy Medical University · CN

Funding

Degradative COMP Fragments as a Biomarker of ArthritisK01AR053210 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIU, CHUANJU · 2007 to 2011
$638k
THE ROLE OF p204 IN OSTEOGENESISR21AR052676 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIU, CHUANJU · 2006 to 2007
$404k
Physiological Role of ADAMTS-7B in ArthritisR03AR052022 · NIAMS · HOSPITAL FOR JOINT DISEASES ORTHO INST · PI LIU, CHUANJU · 2005 to 2007
$261k
Role and Regulation of ADAMTS-12 in the Cartilage CatabolismR03AG029388 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIU, CHUANJU · 2007 to 2008
$137k
NIAMS NIH HHS AR-050620NIAMS NIH HHS AR-052022NIAMS NIH HHS AR-053210NIAMS NIH HHS K01 AR053210NIAMS NIH HHS R03 AR052022NIAMS NIH HHS R21 AR052676NIA NIH HHS AG-029388NIA NIH HHS R03 AG029388
6 · The paper itself

Abstract

Id proteins play important roles in osteogenic differentiation; however, the molecular mechanism remains unknown. In this study, we established that inhibitor of differentiation (Id) proteins, including Id1, Id2, and Id3, associate with core binding factor alpha-1 (Cbfa1) to cause diminished transcription of the alkaline phosphatase (ALP) and osteocalcin (OCL) gene, leading to less ALP activity and osteocalcin (OCL) production. Id acts by inhibiting the sequence-specific binding of Cbfa1 to DNA and by decreasing the expression of Cbfa1 in cells undergoing osteogenic differentiation. p204, an interferon-inducible protein that interacts with both Cbfa1 and Id2, overcame the Id2-mediated inhibition of Cbfa1-induced ALP activity and OCL production. We show that 1) p204 disturbed the binding of Id2 to Cbfa1 and enabled Cbfa1 to bind to the promoters of its target genes and 2) that p204 promoted the translocation from nucleus to the cytoplasm and accelerated the degradation of Id2 by ubiquitin-proteasome pathway during osteogenesis. Nucleus export signal (NES) of p204 is required for the p204-enhanced cytoplasmic translocation and degradation of Id2, because a p204 mutant lacking NES lost these activities. Together, Cbfa1, p204, and Id proteins form a regulatory circuit and act in concert to regulate osteoblast differentiation.

Indexed as

Cell DifferentiationHelix-Loop-Helix MotifsOsteogenesisAlkaline PhosphataseAmino Acid SequenceAnimalsBone Morphogenetic Protein 2Bone Morphogenetic ProteinsCell LineCell NucleusCore Binding Factor alpha SubunitsFemaleHumansInhibitor of Differentiation ProteinsMiceMice, Inbred BALB CAlkaline PhosphataseBMP2 protein, humanBmp2 protein, mouseBone Morphogenetic Protein 2Bone Morphogenetic Proteinscore binding factor alphaCore Binding Factor alpha SubunitsIfi16 protein, mouseInhibitor of Differentiation ProteinsNuclear Export SignalsNuclear ProteinsOsteocalcinPhosphoproteinsProteasome Endopeptidase ComplexTransforming Growth Factor betaUbiquitin

Identifiers

PMID18287524
PMCPMC2366862
OpenAlexW2101058860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.